Floatz logo

UREA, N-(2-CHLOROETHYL)-N'-(4-METHYLCYCLOHEXYL)-N-NITROSO-

Conditioning

First Affiliated Hospital Xi'an Jiaotong UniversitymixturePhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Conditioning cohort.

Asset / SponsorPhaseRating
Evomela
First Affiliated Hospital of Zhejiang University
Phase 3BB
Fludarabine
First Affiliated Hospital of Zhejiang University
Phase 3BB
Cyclophosphamide
First Affiliated Hospital Xi'an Jiaotong University
Phase 2/3B
Busulphan
First Affiliated Hospital Xi'an Jiaotong University
Phase 2/3B
FILGRASTIM
First Affiliated Hospital Xi'an Jiaotong University
Phase 2/3B

View all 15 →

Same molecule, other indications

UREA, N-(2-CHLOROETHYL)-N'-(4-METHYLCYCLOHEXYL)-N-NITROSO- is also rated in:

Allogeneic Hematopoietic Stem Cell TransplantationDormant
B
Indicative ·
62 / 100
View asset →
astrocytic tumorDormant
B
Indicative ·
62 / 100
View asset →
glioblastomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →